Rituximab in ANCA-associated vasculitis: a revolution?

被引：14
|
作者：
Tervaert, Jan Willem Cohen [1 ]
机构：
[1] Maastricht Univ Med Ctr, Dept Internal Med, Div Clin & Expt Immunol, Maastricht, Netherlands
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2011年 / 26卷 / 10期
关键词：
ANCA; pathophysiology; rituximab; therapy; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; WEGENERS-GRANULOMATOSIS; SYSTEMIC VASCULITIS; RENAL VASCULITIS; ANIMAL-MODEL; GLOMERULONEPHRITIS; CYCLOPHOSPHAMIDE; AAV; RTX; ACTIVATION;
D O I：
10.1093/ndt/gfr507
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：3077 / 3079
页数：3
相关论文
共 50 条
  • [1] RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS
    Mukhtyar, Chetan
    RHEUMATOLOGY, 2013, 52 : 5 - 6
  • [2] Rituximab in ANCA-Associated Vasculitis
    Hassan, Romina I.
    Gaffo, Angelo L.
    CURRENT RHEUMATOLOGY REPORTS, 2017, 19 (02)
  • [3] Rituximab in ANCA-Associated Vasculitis
    Romina I. Hassan
    Angelo L. Gaffo
    Current Rheumatology Reports, 2017, 19
  • [4] Rituximab: effective in ANCA-associated vasculitis?
    Ulf Schönermarck
    Kirsten de Groot
    Nature Reviews Nephrology, 2011, 7 : 6 - 8
  • [5] Rituximab: effective in ANCA-associated vasculitis?
    Schoenermarck, Ulf
    de Groot, Kirsten
    NATURE REVIEWS NEPHROLOGY, 2011, 7 (01) : 6 - 8
  • [6] Rituximab to treat ANCA-associated vasculitis
    Guillevin, L.
    Mahr, A.
    REVUE DE MEDECINE INTERNE, 2011, 32 (10): : 591 - 593
  • [7] Rituximab treatment of ANCA-associated vasculitis
    Raffray, Loic
    Guillevin, Loic
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (08) : 899 - 910
  • [8] Rituximab versus azathioprine for ANCA-associated vasculitis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2023, 5 (05): : e252 - e252
  • [9] Rituximab or Cyclophosphamide in ANCA-Associated Renal Vasculitis
    Hebert, Lee A.
    Ardoin, Stacy
    Shim, Rosemarie L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (21): : 2072 - 2073
  • [10] Rituximab maintenance therapy in ANCA-associated vasculitis
    Lorenz, Judith
    AKTUELLE RHEUMATOLOGIE, 2024, 49 (05) : 281 - 281
12345